Search research articles
Contact Us
Filters
Showing results (541-550 of 654) with videos related to
Page
of 66
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1
Andrew J Souers, Dariusz Wodka, Ju Gao, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption
T W von Geldern, D J Hoffman, J A Kester, et al.
Pharmaceutical Research
|
October 23, 2004
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans
Gondi N Kumar, Venkata K Jayanti, Marianne K Johnson, et al.
Proceedings. Biological Sciences
|
February 23, 2022
Ecosystem engineer morphological traits and taxon identity shape biodiversity across the euphotic-mesophotic transition
Sofie E Voerman, Beauregard C Marsh, Ricardo G Bahia, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2013
Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A
David A DeGoey, David A Betebenner, David J Grampovnik, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity
T W von Geldern, A S Tasker, B K Sorensen, et al.
Veterinary Journal (London, England : 1997)
|
June 16, 2010
Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats
Yi Yang, Annette J Dahly-Vernon, Eric A G Blomme, et al.
Journal of Medicinal Chemistry
|
January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists
A S Tasker, B K Sorensen, H S Jae, et al.
Journal of Medicinal Chemistry
|
January 11, 2008
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management
Arthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.
Blood Advances
|
October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years
Vipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Page
of 66
Search research articles
Search
Showing results (541-550 of 654) with videos related to
Sort By:
Page
of 66
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1
Andrew J Souers, Dariusz Wodka, Ju Gao, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption
T W von Geldern, D J Hoffman, J A Kester, et al.
Pharmaceutical Research
|
October 23, 2004
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans
Gondi N Kumar, Venkata K Jayanti, Marianne K Johnson, et al.
Proceedings. Biological Sciences
|
February 23, 2022
Ecosystem engineer morphological traits and taxon identity shape biodiversity across the euphotic-mesophotic transition
Sofie E Voerman, Beauregard C Marsh, Ricardo G Bahia, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2013
Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A
David A DeGoey, David A Betebenner, David J Grampovnik, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity
T W von Geldern, A S Tasker, B K Sorensen, et al.
Veterinary Journal (London, England : 1997)
|
June 16, 2010
Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats
Yi Yang, Annette J Dahly-Vernon, Eric A G Blomme, et al.
Journal of Medicinal Chemistry
|
January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists
A S Tasker, B K Sorensen, H S Jae, et al.
Journal of Medicinal Chemistry
|
January 11, 2008
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management
Arthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.
Blood Advances
|
October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years
Vipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Page
of 66